Galenica further expands online offering and acquires majority stake in Puravita
Galenica AG / Key word(s): TakeoverGalenica further expands online offering and acquires majority stake in Puravita 16.12.2025 / 13:55 CET/CEST Press release
As of beginning of January 2026, Galenica will increase its investment in Puravita AG from 34% to 80% and therefore become the majority shareholder. By taking this step, Galenica is further diversifying its business and pursuing its strategy of optimally linking digital and on-site offerings. In addition to the broad local pharmacy network that includes Amavita, Sun Store and Coop Vitality, their online shops and the joint venture with Redcare in the online-only pharmacy market, Galenica strengthens its offering in the drugstore sector and in particular in the over-the-counter range.
Stephan Mignot, Chief Marketing Pharmacies and member of the Executive Committee of Galenica, says: “Puravita convinces with its excellent customer focus and is very well positioned on the market. With this majority holding, Galenica strengthens its digital offering for customers.” Relevance in the growing online market Puravita has many years of experience in online sales and digital customer interaction. Headquartered in Speicher (AR), the company boasts one of the largest online ranges for pharmacies, drugstores and health food retailers in Switzerland, offering over 45,000 products. The online business is a key growth driver in the areas of health and well-being. With its majority holding in Puravita, Galenica is expanding its business beyond pharmacies.
At the same time, Puravita benefits from Galenica’s market position and infrastructure, particularly in the areas of logistics, product range and marketing. Puravita was founded in 2016 and has been a partner of Galenica since 2020. The company has 48 employees, generates net sales of around CHF 22 million and will continue to be managed by founder Michael Sonderegger. Dates for the diary
For further information, please contact:
Welcome to the Galenica network!Around 8,000 employees at Galenica work tirelessly to improve the health and well-being of the people of Switzerland every day. With its pharmacies, pharmaceutical logistics providers, products, services and home care, Galenica has a broad and successful position in the market. We are shaping the future of healthcare in collaboration with our strong partners – by drawing on the diverse skills and extensive expertise of our entire network. Our ambition is to fulfil the needs of customers and patients in the Swiss healthcare market seamlessly, efficiently and personally. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Additional information about Galenica can be found at www.galenica.com. End of Media ReleaseView original content: EQS News |
| Language: | English |
| Company: | Galenica AG |
| Untermattweg 8 | |
| 3027 Bern | |
| Switzerland | |
| Phone: | +41 058 852 81 11 |
| E-mail: | info@galenica.com |
| Internet: | www.galenica.com |
| ISIN: | CH0360674466 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 2245932 |
| End of News | EQS News Service |
2245932 16.12.2025 CET/CEST